Steritech Pharma Private Limited - Due diligence report

A 360° intelligence report on Steritech Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

1995-12-29 Thane, Maharashtra Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Steritech Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
61/100
Trust Score
Moderate

Steritech Pharma Private Limited is assessed as Moderate with a Trust Score of 61/100. Steritech Pharma Private Limited is an active private limited indian non-government company incorporated in 1995, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 24 Oct 2026 from the latest processed filings. Steritech Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
61/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
10/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
NITIN THACKER 01234567 Director 01/04/2018 6 yrs Approved
VIJAYARAGHAVAN THEKKEVATASSERY NAIR 01234567 Director 01/04/2018 6 yrs Approved
MANGAL DHANAJI KAKADE 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Key managerial personnel: VIJAYARAGHAVAN THEKKEVATASSERY NAIR (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 30
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Asset base grew 1.42 - capacity expansion.
Operating for 30+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 2.1x in a year.
Negative net worth.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment48/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view49/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
06 May 2024
Director ceased
GAURAVI KISHOR PARAB
30 Sep 2022
Director ceased
MANGAL DHANAJI KAKADE
11 Dec 2021
Director appointed
MANGAL DHANAJI KAKADE (Director)
17 Jun 2021
Director appointed
NITIN THACKER (Director)
Director ceased
RATHI VIJAYARAGHAVAN NAIR
29 Dec 1995
Incorporated
Registered with Roc Mumbai Ii
Director appointed
VIJAYARAGHAVAN THEKKEVATASSERY NAIR (Managing Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold the largest single block of equity as per the FY 2020 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Hi-Tech Newchem Private Limited U24100GJ2011PTC064869 Ahmedabad, Gujarat, India
Meenakshi Chemicals Pvt Ltd U24295RJ1985PTC003180 Jaipur, Rajasthan, India
Srm Formulation Private Limited U24303MH2020PTC344254 Aurangabad, Maharashtra, India
Trident Cosmetics India P.Ltd. U24246MH1994PTC078961 Mumbai, Maharashtra, India
Sri Kamakshi Industries Pvt. Ltd. U24110TG1993PTC015766 Hyderabad., Telangana, India
Cenox Chemicals Private Limited U74130TG2003PTC040663 Hyderabad-16., Telangana, India
Fluoro Refrigerants Private Limited U24100DL2011PTC214948 Delhi, Delhi, India
Pcm Chemical India Private Limited U74999DL2007FTC161346 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Steritech Pharma Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Steritech Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Steritech Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 61/100, distress signals and MSME payment-delay disclosures - know whether Steritech Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Steritech Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Steritech Pharma Private Limited an active company?

Steritech Pharma Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Steritech Pharma Private Limited financially healthy?

Steritech Pharma Private Limited has a Financial Health Score of 10/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Steritech Pharma Private Limited?

Its overall Trust Score is 61/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Steritech Pharma Private Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 3 active director(s) are on record.

Does Steritech Pharma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Steritech Pharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Steritech Pharma Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.